Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function

Clinical and Experimental Immunology

Volumn 166, Issue 2, 2011, Pages 191-200

  Burton, C T ^a   Westrop, S J ^a   Eccles James, I ^a   Boasso, A ^a   Nelson, M R ^a   Bower, M ^a   Imami, N ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Anergy suppression tolerance; HIV 1; T cells

Indexed keywords

CD27 ANTIGEN; CD39 ANTIGEN; GAG PROTEIN; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; VIRUS PROTEIN; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; VIRUS LOAD;

ADENOSINE; ANTIGENS, CD; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CYTOMEGALOVIRUS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-7; LYMPHOCYTE COUNT; PHENOTYPE; RNA, VIRAL; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD; VIRAL PROTEINS;

EID: 80053626680     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04451.x     Document Type: Article

References (47)

1. Brenchley J, Price D, Douek D. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006; 7:235-9.
2. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-56.
3. Macatangay B, Rinaldo C. Regulatory T cells in HIV immunotherapy. Future Med 2010; 4:639-47.
4. Oswald-Richter K, Grill SM, Shariat N etal. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004; 2:E198.
5. Ruprecht CR, Gattorno M, Ferlito F etal. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005; 201:1793-803.
6. Seddiki N, Santner-Nanan B, Martinson J etal. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-700.
7. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001; 276:37672-9.
8. Khattri R, Kasprowicz D, Cox T etal. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 2001; 167:6312-20.
9. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337-42.
10. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
11. Yagi H, Nomura T, Nakamura K etal. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16:1643-56.
12. Bopp T, Becker C, Klein M etal. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007; 204:1303-10.
13. Deaglio S, Dwyer KM, Gao W etal. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-65.
14. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90:1600-10.
15. Imami N, Pires A, Hardy G, Wilson J, Gazzard B, Gotch F. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 2002; 76:9011-23.
16. Kinter AL, Hennessey M, Bell A etal. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200:331-43.
17. Douek DC, Brenchley JM, Betts MR etal. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417:95-8.
18. Chase AJ, Sedaghat AR, German JR etal. Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J Virol 2007; 81:12748-57.
19. Andersson J, Boasso A, Nilsson J etal. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005; 174:3143-7.
20. Boasso A, Vaccari M, Hryniewicz A etal. Regulatory T-cell markers, indoleamine 2, 3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J Virol 2007; 81:11593-603.
21. Ji J, Cloyd MW. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int Immunol 2009; 21:283-94.
22. Holmes D, Knudsen G, Mackey-Cushman S, Su L. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem 2007; 282:15973-80.
23. Burton C, Nelson M, Gazzard B, Gotch F, Imami N. Comparison of Phenotypic Analyses of FOXP3+ Regulatory T Cells in HIV-1 Infection 14th Conference on Retroviruses and Opportunistic Infection, Los Angeles, USA. 2007.
24. Yue FY, Kovacs CM, Dimayuga RC, Parks P, Ostrowski MA. HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells. J Immunol 2004; 172:2476-86.
25. Goodwin RG, Friend D, Ziegler SF etal. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990; 60:941-51.
26. Noguchi M, Nakamura Y, Russell SM etal. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993; 262:1877-80.
27. Rallon NI, Lopez M, Soriano V etal. Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol 2009; 155:35-43.
28. Del Pozo-Balado Mdel M, Leal M, Mendez-Lagares G, Pacheco YM. CD4(+)CD25(+/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J Infect Dis 2010; 201:331-5.
29. Sasson SC, Zaunders JJ, Zanetti G etal. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis 2006; 193:505-14.
30. Nilsson J, Boasso A, Velilla PA etal. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-17.
31. Zhang H, Conrad DM, Butler JJ, Zhao C, Blay J, Hoskin DW. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3', 5'-monophosphate and phosphatases. J Immunol 2004; 173:932-44.
32. Zhang N, Yang D, Dong H etal. Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood 2006; 108:38-44.
33. Pulte ED, Broekman MJ, Olson KE etal. CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb Res 2007; 121:309-17.
34. Silber R, Conklyn M. Decreased 5'-nucleotidase activity in a T lymphocyte subpopulation from patients with B cell chronic lymphocytic leukemia. Blood 1984; 64:479-81.
35. Johnson SM, North ME, Asherson GL, Allsop J, Watts RW, Webster AD. Lymphocyte purine 5'-nucleotidase deficiency in primary hypogammaglobulinaemia. Lancet 1977; 1:168-70.
36. Peola S, Borrione P, Matera L, Malavasi F, Pileri A, Massaia M. Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities. J Immunol 1996; 157:4354-62.
37. Bofill M, Parkhouse RM. The increased CD38 expressed by lymphocytes infected with HIV-1 is a fully active NADase. Eur J Immunol 1999; 29:3583-7.
38. Barat C, Martin G, Beaudoin AR, Sevigny J, Tremblay MJ. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active. J Mol Biol 2007; 371:269-82.
39. Kinter AL, Horak R, Sion M etal. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses 2007; 23:438-50.
40. Radziewicz H, Dunham RM, Grakoui A. PD-1 tempers Tregs in chronic HCV infection. J Clin Invest 2009; 119:450-3.
41. Rosignoli G, Lim CH, Bower M, Gotch F, Imami N. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol 2009; 157:90-7.
42. Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol 2008; 83:254-62.
43. Weiss L, Letimier FA, Carriere M etal. In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients. Proc Natl Acad Sci USA 2010; 107:10632-7.
44. Ndhlovu LC, Sinclair E, Epling L etal. IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. J Clin Immunol 2010; 30:681-92.
45. Rech AJ, Vonderheide RH. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann NY Acad Sci 2009; 1174:99-106.
46. Hryniewicz A, Boasso A, Edghill-Smith Y etal. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006; 108:3834-42.
47. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3(+) regulatory T cells. Nat Rev Immunol 2011; 11:119-30.